METTL3-m6A-EGFR-axis drives lenvatinib resistance in hepatocellular carcinoma.
Wang L, Yang Q, Zhou Q, Fang F, Lei K, Liu Z, Zheng G, Zhu L, Huo J, Li X, Peng S, Kuang M, Lin S, Huang M, Xu L.
Wang L, et al. Among authors: peng s.
Cancer Lett. 2023 Apr 10;559:216122. doi: 10.1016/j.canlet.2023.216122. Epub 2023 Mar 9.
Cancer Lett. 2023.
PMID: 36898427